NCT00107874View on ClinicalTrials.gov

Oral Misoprostol Versus Intravenous Oxytocin in Preventing Blood Loss After Non-scheduled Cesarean Section

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

February 28, 2002

Study Completion Date

February 28, 2002

Conditions

Postpartum Hemorrhage

Interventions

DRUG

misoprostol

Trial Locations (1)

4031

Women's University Hospital, Basel, Basel

All Listed Sponsors

lead

University Hospital, Basel, Switzerland

OTHER

NCT00107874 - Oral Misoprostol Versus Intravenous Oxytocin in Preventing Blood Loss After Non-scheduled Cesarean Section | Biotech Hunter | Biotech Hunter